| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |